Monte Rosa Therapeutics(Glue) Financials: Operating Profit Margin Compared To Industry Average, Plus Other Key Ratios
Company Report for GLUE
Report - operating profit margin
This chart shows the historical trend of operating profit margin for GLUE compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Operating Profit Margin
Definition: Operating profit margin focuses on profits from the company’s core business — before interest payments and taxes. It reflects how well the business manages operating costs relative to sales. Strong operating margins show efficient day-to-day operations. Shrinking margins may reveal rising overhead, pricing weakness, or declining efficiency.
Interpretation:
• In '2024', GLUE's operating profit margin was -107.3%, highlighting profit earned from core business operations. Industry average for Biotechnology: Biological Products (No Diagnostic Substances) in '2024' stood at -182.6%.
Overall, GLUE's operating profit margin has been volatile but generally stable over the past 1 years.
Formula: Operating Profit Margin = Operating Income / Revenue
Good Range: Often 10%-30% depending on business model.